Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Many checkpoints on the road to cell death: regulation of Fas-FasL interactions and Fas signaling in peripheral immune responses.

Ramaswamy M, Cleland SY, Cruz AC, Siegel RM.

Results Probl Cell Differ. 2009;49:17-47. doi: 10.1007/400_2008_24. Review.

3.

Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict.

O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC, Shanahan F.

Ann N Y Acad Sci. 2000 Jun;910:178-92; discussion 193-5. Review.

PMID:
10911913
4.

Expression and function of Fas and Fas ligand on peripheral blood lymphocytes in normal subjects.

Kawakami A, Eguchi K, Matsuoka N, Tsuboi M, Koji T, Urayama S, Nakashima T, Kawabe Y, Nagataki S.

J Lab Clin Med. 1998 Nov;132(5):404-13.

PMID:
9823934
5.

Fas/FasL pathway participates in resolution of mucosal inflammatory response early during HSV-2 infection.

Krzyzowska M, Baska P, Grochowska A, Orlowski P, Nowak Z, Winnicka A.

Immunobiology. 2014 Jan;219(1):64-77. doi: 10.1016/j.imbio.2013.08.002. Epub 2013 Aug 15.

PMID:
24028839
6.

Molecular and cellular mechanisms regulating T and B cell apoptosis through Fas/FasL interaction.

Ju ST, Matsui K, Ozdemirli M.

Int Rev Immunol. 1999;18(5-6):485-513. Review.

PMID:
10672498
7.

Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-x(L).

Huang DC, Hahne M, Schroeter M, Frei K, Fontana A, Villunger A, Newton K, Tschopp J, Strasser A.

Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):14871-6.

10.

Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).

Ostrand-Rosenberg S, Sinha P, Chornoguz O, Ecker C.

Cancer Immunol Immunother. 2012 Aug;61(8):1319-25. doi: 10.1007/s00262-012-1269-6. Epub 2012 May 1. Review.

PMID:
22546994
11.

Actinobacillus actinomycetemcomitans induces apoptosis of T lymphocytes by the Fas and Fas ligand pathway.

Nalbant A, Zadeh HH.

Oral Microbiol Immunol. 2002 Oct;17(5):277-84.

PMID:
12354208
12.

Non-apoptotic Fas signaling.

Wajant H, Pfizenmaier K, Scheurich P.

Cytokine Growth Factor Rev. 2003 Feb;14(1):53-66. Review.

PMID:
12485619
13.

Storage, expression and function of Fas ligand, the key death factor of immune cells.

Lettau M, Paulsen M, Kabelitz D, Janssen O.

Curr Med Chem. 2008;15(17):1684-96. Review.

PMID:
18673218
14.

Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma.

Choi C, Park JY, Lee J, Lim JH, Shin EC, Ahn YS, Kim CH, Kim SJ, Kim JD, Choi IS, Choi IH.

J Immunol. 1999 Feb 15;162(4):1889-95.

16.

Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.

Huerta-Yepez S, Vega M, Garban H, Bonavida B.

Clin Immunol. 2006 Sep;120(3):297-309. Epub 2006 Jun 19.

PMID:
16784892
17.
18.

The role of Fas/FasL interactions in the regulation of B cell function.

Jacobson BA, Rothstein TL, Marshak-Rothstein A.

Behring Inst Mitt. 1996 Oct;(97):185-99. Review.

PMID:
8950476
19.

The many roles of FAS receptor signaling in the immune system.

Strasser A, Jost PJ, Nagata S.

Immunity. 2009 Feb 20;30(2):180-92. doi: 10.1016/j.immuni.2009.01.001. Review.

20.

HLA class II-mediated death is induced via Fas/Fas ligand interactions in human splenic B lymphocytes.

Truman JP, Choqueux C, Tschopp J, Vedrenne J, Le Deist F, Charron D, Mooney N.

Blood. 1997 Mar 15;89(6):1996-2007.

Supplemental Content

Support Center